Page last updated: 2024-08-21

isoxazoles and tamoxifen

isoxazoles has been researched along with tamoxifen in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's4 (80.00)24.3611
2020's1 (20.00)2.80

Authors

AuthorsStudies
Andò, S; Barone, I; Bonofiglio, D; Catalano, S; Fuqua, SA; Gelsomino, L; Giordano, C; Panza, S; Rizza, P; Vizza, D1
Bouajila, J; Filali, I; Jannet, HB; Romdhane, A; Znati, M1
Bhatnagar, S; Chandrasekhar, L; Kaushik, S; Lekshmi, A; Nair, M; Sanawar, R; Santhoshkumar, TR1
Balachandran, P; Gowramma, B; Kalirajan, R; Pandiselvi, A1
Blackshear, CP; Burcham, A; Chinta, MS; Cui, L; Foster, DS; Gulati, GS; Gurtner, GC; Hu, MS; Januszyk, M; Jones, RE; Kin, CJ; King, ME; Lerbs, T; Longaker, MT; Manjunath, A; Marshall, CD; Mascharak, S; Moore, AL; Nguyen, A; Norton, JA; Ransom, RC; Salhotra, A; Shelton, AA; Titan, AL; Wernig, G1

Other Studies

5 other study(ies) available for isoxazoles and tamoxifen

ArticleYear
Farnesoid X receptor inhibits tamoxifen-resistant MCF-7 breast cancer cell growth through downregulation of HER2 expression.
    Oncogene, 2011, Sep-29, Volume: 30, Issue:39

    Topics: Antineoplastic Agents, Hormonal; Breast Neoplasms; Cell Line, Tumor; Cell Proliferation; Chenodeoxycholic Acid; Chromatin Immunoprecipitation; Down-Regulation; Drug Resistance, Neoplasm; Electrophoretic Mobility Shift Assay; Epidermal Growth Factor; Female; Gene Expression Regulation, Neoplastic; Humans; Isoxazoles; Mitogen-Activated Protein Kinase 3; NF-kappa B; Promoter Regions, Genetic; Receptor, ErbB-2; Receptors, Cytoplasmic and Nuclear; Receptors, Estrogen; Reverse Transcriptase Polymerase Chain Reaction; Signal Transduction; Tamoxifen

2011
Synthesis of New Harmine Isoxazoles and Evaluation of their Potential Anti-Alzheimer, Anti-inflammatory, and Anticancer Activities.
    Medicinal chemistry (Shariqah (United Arab Emirates)), 2016, Volume: 12, Issue:2

    Topics: Alzheimer Disease; Anti-Inflammatory Agents, Non-Steroidal; Antineoplastic Agents; Carbon-13 Magnetic Resonance Spectroscopy; Cholinesterase Inhibitors; Cycloaddition Reaction; Harmine; HCT116 Cells; Humans; Isoxazoles; Lipoxygenase Inhibitors; MCF-7 Cells; Peganum; Proton Magnetic Resonance Spectroscopy; Structure-Activity Relationship; Tamoxifen; Xanthine Oxidase

2016
ER alpha selective chromone, isoxazolylchromones, induces ROS-mediated cell death without autophagy.
    Chemical biology & drug design, 2019, Volume: 94, Issue:1

    Topics: Antineoplastic Agents; Apoptosis; Autophagy; Binding Sites; Cell Cycle Checkpoints; Cell Line, Tumor; Chromones; Down-Regulation; Estrogen Receptor alpha; Estrogen Receptor beta; Humans; Isoxazoles; Ligands; Molecular Docking Simulation; Protein Structure, Tertiary; Reactive Oxygen Species; RNA Interference; RNA, Small Interfering; Signal Transduction; Tamoxifen

2019
In-silico Design, ADMET Screening, MM-GBSA Binding Free Energy of Some Novel Isoxazole Substituted 9-Anilinoacridines as HER2 Inhibitors Targeting Breast Cancer.
    Current drug research reviews, 2019, Volume: 11, Issue:2

    Topics: Amsacrine; Antineoplastic Agents; Breast Neoplasms; Computer Simulation; Drug Design; Ethacridine; Female; Humans; Hydrogen Bonding; Isoxazoles; Models, Molecular; Molecular Dynamics Simulation; Receptor, ErbB-2; Structure-Activity Relationship; Tamoxifen

2019
Elucidating the fundamental fibrotic processes driving abdominal adhesion formation.
    Nature communications, 2020, 08-13, Volume: 11, Issue:1

    Topics: Animals; Benzophenones; Cells, Cultured; CRISPR-Cas Systems; Doxycycline; Fibroblasts; Fluorescent Antibody Technique; Gastrointestinal Diseases; Humans; Immunohistochemistry; Isoxazoles; Liposomes; Mice; NIH 3T3 Cells; Parabiosis; RNA, Messenger; Tamoxifen; Tissue Adhesions

2020